FTH: the cash flow

Cash Flow Overview

Change in Cash

$18,235K

Free Cash flow

-$26,412K

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2026-06-30

Net loss

-186,243

Stock-based compensation expense

17,381

Depreciation and amortization

Accretion on marketable securities

-1,126

Non-cash lease expense

770

Amortization of financing lease right-of-use assets

Acquired in-process research and development from the acquisition of faeth therapeutics

-132,957

Loss on asset disposal

Prepaid expenses

-10,360

Other assets

-138

Accounts payable and accrued liabilities

247

Compensation and employee benefits

-108

Operating lease liabilities

-837

Net cash used in operating activities

-26,406

Purchases of property and equipment

Purchases of short-term investments

158,560

Maturities of short-term investments

12,600

Proceeds from sale of property and equipment

Net cash assumed in the acquisition of faeth therapeutics

-6,464

Net cash (used in) provided by investing activities

-139,502

Principal payments for financing leases

Proceeds from the sale of financing lease assets

Proceeds from issuance of series b redeemable convertible preferred stock

200,000

Issuance costs from the private placement issuance of series b redeemable convertible preferred stock

16,908

Payment of employee restricted stock tax withholdings

Employee stock purchase plan proceeds

Cash in lieu of fractional shares for reverse stock split

Exercise of options into common stock

1,131

Net cash provided by (used in) financing activities

184,143

Net increase in cash and cash equivalents

18,235

Cash and cash equivalents at beginning of period

8,668

Cash and cash equivalents at the end of period

26,903

Time Plot

Show the time plot by selecting a row from the table.